Dose escalation resets One thing to know: dose increases can temporarily restart some of these patterns
Clinical eligibility for brand-name GLP-1 medications generally requires an adult patient to have a body mass index (BMI) of 30 or greater, or a BMI of 27 or higher paired with a weight-related health condition such as high blood pressure
However, it is advised to discontinue use if you experience any discomfort
Useful investigations include: Cytokine panels to assess ongoing inflammatory activation Lymphocyte subset analysis to characterize immune dysfunction patterns Organic acid testing to evaluate mitochondrial function and cellular energy metabolism Comprehensive stool analysis to assess microbiome status and intestinal permeability Cortisol and adrenal function testing Viral reactivation panels including EBV and CMV antibody titer tests Autonomic function testing, including heart rate variability analysis, and Advanced nutrient status including glutathione, CoQ10, NAD+ markers, B vitamins, and magnesium This holistic picture of your health allows for targeted interventions rather than generic symptom management, fostering more effective long COVID treatment
Eryptosis in autoimmune haemolytic anaemia
This recipe is ready and on the table in 30 minutes